Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
CHV Capital
AddedFeb 15, 2024
UpdatedJun 28, 2026
CHV Capital

CHV Capital

Operating

Clarian Health Ventures: A US-based venture capital fund specializing in early-stage healthcare investments.

Location
Indianapolis, IN, US
Founded
2007
Firm
Compare
Portfolio
Employees
Website

CHV Capital is a venture capital fund focused on early-stage investments in the healthcare sector within the United States. The firm primarily targets companies in various stages of development, from Series A to Series D rounds, demonstrating a flexible investment approach across the growth spectrum.

Notable portfolio companies include Health Catalyst, which has raised $119 million, and NeoChord, with $20 million in funding. CHV Capital's investments span diverse healthcare subsectors, including medical devices (NeoChord, Nico), healthcare IT (Health Catalyst, PerfectServe), and biotechnology (Cs-Keys, Perfinity Biosciences). This diversified portfolio reflects the firm's commitment to supporting innovative healthcare solutions across multiple domains.

CHV Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments8
Current Portfolio Count5
Total Portfolio Exits0

Top Investment Stages

Series C2 (25.0%)
Series D2 (25.0%)
Series Unknown2 (25.0%)
Series A1 (12.5%)
Series B1 (12.5%)

Stage Mix

Series C 25%Series D 25%Series Unknown 25%Series A 13%Series B 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

PerfectServe logo

PerfectServe

NeoChord logo

NeoChord

Health Catalyst logo

Health Catalyst

Nico logo

Nico

Perfinity Biosciences logo

Perfinity Biosciences

Cs-Keys logo

Cs-Keys

CHV Capital - Similar Investment Firms

Health Catalyst Capital logo

Health Catalyst Capital

Catalyst Health Ventures logo

Catalyst Health Ventures

CHL Medical Partners logo

CHL Medical Partners

VentureHealth logo

VentureHealth

venturehealth.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Health2047 Capital Partners logo

Health2047 Capital Partners

Chiesi Ventures logo

Chiesi Ventures

chiesiventures.com

Continuum Health Ventures logo

Continuum Health Ventures

continuumhealth.vc

Charter Venture Group logo

Charter Venture Group

NeuroVentures Capital logo

NeuroVentures Capital

neuroventures.com

Ascension Ventures logo

Ascension Ventures

Cadence Healthcare Ventures logo

Cadence Healthcare Ventures

cadencehcvc.com

Echo Health Ventures logo

Echo Health Ventures

HealthTech Capital logo

HealthTech Capital

Lrvhealth logo

Lrvhealth

lrvhealth.com

CHV Capital - Classification

Also Known As
  • Clarian Health Ventures Inc
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end